Psoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.
5 affiliations
- 1Medicine, Edward Via College of Osteopathic Medicine, Auburn, USA.
- 2Internal Medicine, Edward Via College of Osteopathic Medicine, Fort Walton Beach, USA.
- 3Pediatrics, Edward Via College of Osteopathic Medicine, Huntsville, USA.
- 4Obstetrics and Gynecology, Edward Via College of Osteopathic Medicine, Fort Walton Beach, USA.
- 5Clinical Affairs, Edward Via College of Osteopathic Medicine, Auburn, USA.
Abstract
Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease. Presentations can vary, but common manifestations include peripheral arthritis, dactylitis, enthesitis, nail changes, and skin changes, including psoriasis. Diagnosis is often challenging due to the absence of specific biomarkers, variable clinical presentation, and overlap with conditions such as osteoarthritis and fibromyalgia. These diagnostic obstacles contribute to frequent misdiagnosis and delay in treatment, which, over time, leads to irreversible joint damage, functional impairment, and increased comorbidities. A 62-year-old woman with a 15-year history of chronic pain attributed to fibromyalgia and osteoarthritis presented to primary care with persistent hand and foot pain and worsening depressive symptoms. Prior treatments failed to provide relief. Imaging and laboratory evaluation were not consistent with her previous diagnoses of fibromyalgia and osteoarthritis. Although she lacked characteristic psoriatic skin lesions, further history revealed a family history of psoriasis in her daughter and grandson. This finding prompted consideration of PsA, and the diagnosis was made based on clinical presentation and history. The patient was started on disease-modifying antirheumatic drug therapy and escitalopram, with significant improvement in both pain and mood within one month. This case exemplifies the impacts of delayed diagnosis in a patient with PsA without cutaneous manifestations. Common misdiagnoses of PsA can include fibromyalgia, osteoarthritis, and rheumatoid arthritis due to overlapping subjective and objective findings, making diagnosis difficult. This delay leads to prolonged initiation of treatment and thus results in further joint damage, functional decline, and mental health impacts. Quicker suspicion and thorough history taking in patients with chronic musculoskeletal pain unresponsive to treatment could potentially improve diagnostic delay trends of PsA, even in the absence of cutaneous findings.
Related
- Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients with Frontotemporal Lobar Degeneration
- A Diagnostic Conundrum: A Hemorrhagic Adrenal Mass With Discordant Radiological, Biochemical, and Pathologic Features
- Diagnostic performance and pathologic associations of the UroVysion assay in patients with upper tract lesions and negative urinary cytology: a large-scale real-world study of 1,256 patients.
- Diagnostic performance of FIB-4 in detecting advanced liver fibrosis in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis using methotrexate.
- Neglected arboviruses in South America: clinical manifestations and diagnostic challenges
BibTeX
@article{tomlinson2026psoriatic,
title = {{Psoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.}},
author = {Paris Tomlinson and Kelsey N Sauers and Emeri Nosal and Brae Davies and Colleen E McGarvey and Johnny Stackhouse},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.117097},
url = {https://europepmc.org/article/MED/42953876},
note = {CC BY},
}
RIS
TY - JOUR
TI - Psoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.
AU - Paris Tomlinson
AU - Kelsey N Sauers
AU - Emeri Nosal
AU - Brae Davies
AU - Colleen E McGarvey
AU - Johnny Stackhouse
PY - 2026
DA - 2026/09/28
JO - Cureus
DO - 10.7759/cureus.117097
UR - https://europepmc.org/article/MED/42953876
AB - Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease. Presentations can vary, but common manifestations include peripheral arthritis, dactylitis, enthesitis, nail changes, and skin changes, including psoriasis. Diagnosis is often challenging due to the absence of specific biomarkers, variable clinical presentation, and overlap with conditions such as osteoarthritis and fibromyalgia. These diagnostic obstacles contribute to frequent misdiagnosis and delay in treatment, which, over time, leads to irreversible joint damage, functional impairment, and increased comorbidities. A 62-year-old woman with a 15-year history of chronic pain attributed to fibromyalgia and osteoarthritis presented to primary care with persistent hand and foot pain and worsening depressive symptoms. Prior treatments failed to provide relief. Imaging and laboratory evaluation were not consistent with her previous diagnoses of fibromyalgia and osteoarthritis. Although she lacked characteristic psoriatic skin lesions, further history revealed a family history of psoriasis in her daughter and grandson. This finding prompted consideration of PsA, and the diagnosis was made based on clinical presentation and history. The patient was started on disease-modifying antirheumatic drug therapy and escitalopram, with significant improvement in both pain and mood within one month. This case exemplifies the impacts of delayed diagnosis in a patient with PsA without cutaneous manifestations. Common misdiagnoses of PsA can include fibromyalgia, osteoarthritis, and rheumatoid arthritis due to overlapping subjective and objective findings, making diagnosis difficult. This delay leads to prolonged initiation of treatment and thus results in further joint damage, functional decline, and mental health impacts. Quicker suspicion and thorough history taking in patients with chronic musculoskeletal pain unresponsive to treatment could potentially improve diagnostic delay trends of PsA, even in the absence of cutaneous findings.
SN - 2168-8184
ER -